相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials
Paul Guedeney et al.
EUROPEAN HEART JOURNAL (2022)
Meta-GWAS of PCSK9 levels detects two novel loci at APOB and TM6SF2
Janne Pott et al.
HUMAN MOLECULAR GENETICS (2022)
Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Cognitive Function
Daniel B. Rosoff et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)
Mendelian randomization
Eleanor Sanderson et al.
NATURE REVIEWS METHODS PRIMERS (2022)
PCSK9 genetic variants and cognitive abilities: a large-scale Mendelian randomization study
Donald M. Lyall et al.
ARCHIVES OF MEDICAL SCIENCE (2021)
Genetic Liability to Depression and Risk of Coronary Artery Disease, Myocardial Infarction, and Other Cardiovascular Outcomes
Yunlong Lu et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
The power of genetic diversity in genome-wide association studies of lipids
Sarah E. Graham et al.
NATURE (2021)
Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development
Michael V. Holmes et al.
NATURE REVIEWS CARDIOLOGY (2021)
Causal inference with observational data: the need for triangulation of evidence
Gemma Hammerton et al.
PSYCHOLOGICAL MEDICINE (2021)
In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates
Kiran Musunuru et al.
NATURE (2021)
In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels
Tanja Rothgangl et al.
NATURE BIOTECHNOLOGY (2021)
Effect of Statin Therapy on Cognitive Decline and Incident Dementia in Older Adults
Zhen Zhou et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Analysis of Female Enrollment and Participant Sex by Burden of Disease in US Clinical Trials Between 2000 and 2020
Jecca R. Steinberg et al.
JAMA NETWORK OPEN (2021)
Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort
Golam M. Khandaker et al.
MOLECULAR PSYCHIATRY (2020)
Lipid Lowering and Alzheimer Disease Risk: A Mendelian Randomization Study
Dylan M. Williams et al.
ANNALS OF NEUROLOGY (2020)
Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer
James Yarmolinsky et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Major depressive disorder and cardiometabolic diseases: a bidirectional Mendelian randomisation study
Bowen Tang et al.
DIABETOLOGIA (2020)
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Kausik K. Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
Frederick J. Raal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric Disorders
Emma M. O'Connell et al.
FRONTIERS IN NEUROSCIENCE (2020)
Genetic drug target validation using Mendelian randomisation
Amand F. Schmidt et al.
NATURE COMMUNICATIONS (2020)
Evinacumab for Homozygous Familial Hypercholesterolemia
Frederick J. Raal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Sex differences in depression: Insights from clinical and preclinical studies
Rand S. Eid et al.
PROGRESS IN NEUROBIOLOGY (2019)
Gender Differences in Response to PCSK9 Inhibitor Therapy
Paul Ziajka
Journal of Clinical Lipidology (2019)
LDL cholesterol relates to depression, its severity, and the prospective course
Claudia Johanna Wagner et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)
Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial
Lawrence A. Leiter et al.
DIABETES CARE (2019)
PCSK9 inhibitors: clinical evidence and implementation
Marc S. Sabatine
NATURE REVIEWS CARDIOLOGY (2019)
Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption
Jack Bowden et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2019)
Gender differences in subtypes of depression by first incidence and age of onset: a follow-up of the Lundby population
Mats Bogren et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2018)
Methylomic profiling and replication implicates deregulation of PCSK9 in alcohol use disorder
F. W. Lohoff et al.
MOLECULAR PSYCHIATRY (2018)
Evaluating the potential role of pleiotropy in Mendelian randomization studies
Gibran Hemani et al.
HUMAN MOLECULAR GENETICS (2018)
Risk of Neuropsychiatric Adverse Effects of Lipid-Lowering Drugs: A Mendelian Randomization Study
Jahad Alghamdi et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Differences Between Women and Men in Incidence Rates of Dementia and Alzheimer's Disease
Christopher R. Beam et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
The MR-Base platform supports systematic causal inference across the human phenome
Gibran Hemani et al.
ELIFE (2018)
Hyperlipidemia in Stroke Pathobiology and Therapy: Insights and Perspectives
Romain Menet et al.
FRONTIERS IN PHYSIOLOGY (2018)
Nonstatin Therapy for Dyslipidemia Current and Future Directions
Haitham M. Ahmed et al.
CIRCULATION RESEARCH (2018)
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
G. G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data
Olena O. Yavorska et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2017)
Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab Pooled Data From Randomized Trials
Jennifer G. Robinson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
REVEALing the effect of CETP inhibition in cardiovascular disease
Michael V. Holmes et al.
NATURE REVIEWS CARDIOLOGY (2017)
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization
Jack Bowden et al.
STATISTICS IN MEDICINE (2017)
Orienting the causal relationship between imprecisely measured traits using GWAS summary data
Gibran Hemani et al.
PLOS GENETICS (2017)
Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population
Anna Fry et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2017)
Design and rationale of the EBBINGHAUS trial: A phase 3, double-blind, placebo-controlled, multicenter study to assess the effect of evolocumab on cognitive function in patients with clinically evident cardiovascular disease and receiving statin background lipid-lowering therapyA cognitive study of patients enrolled in the FOURIER trial
Robert P. Giugliano et al.
CLINICAL CARDIOLOGY (2017)
Heart Disease and Stroke Statistics-2016 Update A Report From the American Heart Association
Dariush Mozaffarian et al.
CIRCULATION (2016)
Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator
Jack Bowden et al.
GENETIC EPIDEMIOLOGY (2016)
Bias due to participant overlap in two-sample Mendelian randomization
Stephen Burgess et al.
GENETIC EPIDEMIOLOGY (2016)
Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic
Jack Bowden et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2016)
Prognosis of Variant Angina Manifesting as Aborted Sudden Cardiac Death
Jung-Min Ahn et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Multivariable Mendelian Randomization: The Use of Pleiotropic Genetic Variants to Estimate Causal Effects
Stephen Burgess et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2015)
Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression
Jack Bowden et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2015)
Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders
Sarah G. Helton et al.
PHARMACOGENOMICS (2015)
The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
Kristin G. Ardlie et al.
SCIENCE (2015)
Age-dependent effect of high cholesterol diets on anxiety-like behavior in elevated plus maze test in rats
Xu Hu et al.
BEHAVIORAL AND BRAIN FUNCTIONS (2014)
Mendelian randomization: genetic anchors for causal inference in epidemiological studies
George Davey Smith et al.
HUMAN MOLECULAR GENETICS (2014)
Calculating statistical power in Mendelian randomization studies
Marie-Jo A. Brion et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2013)
Discovery and refinement of loci associated with lipid levels
Cristen J. Willer et al.
NATURE GENETICS (2013)
The Genotype-Tissue Expression (GTEx) project
John Lonsdale et al.
NATURE GENETICS (2013)
Pharmacogenetics of antidepressant drugs: current clinical practice and future directions
Sneha Narasimhan et al.
PHARMACOGENOMICS (2012)
Avoiding bias from weak instruments in Mendelian randomization studies
Stephen Burgess et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2011)
Changes in Memory Function and Neuronal Activation Associated with Atorvastatin Therapy
Beth A. Parker et al.
PHARMACOTHERAPY (2010)
Statin-Associated Adverse Cognitive Effects: Survey Results from 171 Patients
Marcella A. Evans et al.
PHARMACOTHERAPY (2009)
Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study
Sheila M. Marcus et al.
COMPREHENSIVE PSYCHIATRY (2008)
Mendelian randomization as an instrumental variable approach to causal inference
Vanessa Didelez et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2007)
Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime
D Steinberg
NATURE MEDICINE (2002)